Insufficient scRNA-seq data for expression of NAT2 at single-cell level.
Insufficient scRNA-seq data for expression of NAT2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 2146.16 | 226 / 226 | 72% | 12.96 | 292 / 406 |
intestine | 73% | 258.33 | 705 / 966 | 80% | 10.49 | 422 / 527 |
kidney | 82% | 19.12 | 73 / 89 | 23% | 1.07 | 210 / 901 |
uterus | 94% | 26.55 | 160 / 170 | 11% | 0.37 | 50 / 459 |
brain | 73% | 9.48 | 1936 / 2642 | 30% | 0.80 | 215 / 705 |
spleen | 100% | 55.95 | 241 / 241 | 0% | 0 | 0 / 0 |
prostate | 88% | 22.47 | 215 / 245 | 10% | 0.20 | 49 / 502 |
breast | 56% | 8.79 | 258 / 459 | 41% | 2.92 | 460 / 1118 |
stomach | 24% | 1.50 | 85 / 359 | 68% | 8.25 | 195 / 286 |
lung | 73% | 10.93 | 420 / 578 | 18% | 1.03 | 204 / 1155 |
ovary | 83% | 9.88 | 149 / 180 | 6% | 0.18 | 25 / 430 |
adrenal gland | 70% | 5.94 | 181 / 258 | 10% | 0.33 | 24 / 230 |
esophagus | 40% | 3.22 | 579 / 1445 | 28% | 1.82 | 51 / 183 |
heart | 55% | 4.55 | 470 / 861 | 0% | 0 | 0 / 0 |
bladder | 24% | 1.76 | 5 / 21 | 27% | 3.01 | 137 / 504 |
adipose | 41% | 3.49 | 498 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 9% | 0.45 | 29 / 328 | 25% | 1.05 | 44 / 178 |
skin | 32% | 2.69 | 585 / 1809 | 1% | 0.03 | 5 / 472 |
blood vessel | 33% | 2.36 | 438 / 1335 | 0% | 0 | 0 / 0 |
thymus | 30% | 1.74 | 193 / 653 | 0% | 0.01 | 2 / 605 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.11 | 4 / 45 |
peripheral blood | 7% | 0.91 | 67 / 929 | 0% | 0 | 0 / 0 |
muscle | 5% | 0.29 | 42 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.05 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0004060 | Molecular function | arylamine N-acetyltransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046990 | Molecular function | N-hydroxyarylamine O-acetyltransferase activity |
Gene name | NAT2 |
Protein name | Arylamine N-acetyltransferase 2 (EC 2.3.1.5) arylamine N-acetyltransferase (EC 2.3.1.5) Arylamine N-acetyltransferase 2 (EC 2.3.1.5) (Arylamide acetylase 2) (N-acetyltransferase type 2) (NAT-2) (Polymorphic arylamine N-acetyltransferase) (PNAT) |
Synonyms | hCG_27151 AAC2 |
Description | FUNCTION: Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens. |
Accessions | A4Z6T9 A4Z6U9 P11245 E7EWF9 A4Z7H3 A4Z6V9 A4Z6Y3 A4Z6U6 A4Z7P9 A0A0S2A4Q6 A4Z6Y1 A9X816 A4Z7V0 A9X854 A4Z867 Q400I5 A9X868 A4Z6T8 A4Z787 A4Z7K4 ENST00000286479.4 A4Z737 A0A0S2A5S1 A0A0S2A5X5 A4Z7F6 Q400I7 A4Z6Y5 A9X7U6 A4Z6T7 A4Z6U4 A4Z7J7 A9X7X6 A9X844 A4Z6U7 ENST00000520116.1 A9X7Q9 A0A0S2A5J2 |